Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

$500K on the table in AI vs. COVID contest

Nonprofit competition organizer XPrize is partnering with global tech consultancy Cognizant to award AI innovators in a pandemic response challenge.

Surprise medical bills cost younger adults more

Millennials are feeling the pain of surprise medical bills more acutely than the generations that preceded them.

Measles coiled to do children far more harm than COVID-19

Unless the world takes action now, millions of children will contract measles next year. Hundreds of thousands could die, and much of the suffering will have been preventable.

Thumbnail

4 forces favoring, 5 working against Biden’s wish to lower Medicare eligibility age

President-elect Joe Biden wants to drop Medicare’s eligibility age to 60. If he succeeds, the move might bring in well more than 20 million new enrollees. What are the odds he’ll plant that piece of a potentially sweeping healthcare agenda?  

Life sciences going all in with AI, with many companies spending upwards of $50M—and counting

The COVID crisis will spur leaders of life sciences companies around the world to focus on longstanding pain points that AI could help alleviate. And the execs are looking to put their money where their responses are.

3 recent notable approvals of medical AI

Along with AI, this ongoing list includes regulatory clearances of virtual and augmented reality, 3D printing and other emerging technologies targeted for healthcare.

Thumbnail

3 areas newly ripe for employer-driven change in healthcare policy

A healthcare research firm specializing in purchasing has considered the post-election landscape from the vantage point of large employers offering health benefits to their workers.

Health execs best consider now what a ‘Bidencare’ might look like later

As Joe Biden makes plans to intensify the federal response to the COVID crisis, he can expect support on that agenda item from 77% of Democrats, 62% of independents, 55% of Republicans and 50% of others.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup